Fundraising Fox

Medical Devices Investors & VC Firms in North America

191 firms in this list, with a median first check of $540K. 52 of them lead rounds. Generated from verified public data and updated continuously.

Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
30 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
42 people
Lightstone Ventures
Portola ValleyPre-Seed–Late Stage
30 people
The Argentum Group
New YorkGrowth–Late Stage
9 people
Summit Partners
BostonSeries B–Late Stage$10M – $500M
1 person
Artesian
AustraliaPre-Seed–Late Stage
42 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K – $500K
21 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Jeito Capital
Paris
34 people
Verge HealthTech Fund
SingaporePre-Seed–Series B$500K – $1.5M
24 people
Claret Capital Partners
LondonSeries A–Late Stage
29 people
Next Level Ventures
Des MoinesSeed–Late Stage$500K – $5M
16 people
SPRINGROCK VENTURES
SeattleSeed–Late Stage$2M – $5M
14 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
17 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
25 people
Sanderling Ventures
San MateoSeed–Late Stage$50K – $1M
9 people
Broadview Ventures
BostonSeed–Late Stage
21 people
First Analysis
ChicagoSeries A–Late Stage
23 people
Innovobot
MontrealPre-Seed–Series A$182.5K – $365K
30 people
Arkin Capital
HerzliyaSeed–Late Stage
28 people
Air Street Capital
St. Peter PortPre-Seed–Growth$500K – $10M
6 people
Essex Woodlands Healthcare Partners
New YorkGrowth–Late Stage$20M – $80M
18 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
21 people
Monograph Capital Partners
LondonSeed–Series B
20 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.